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1. Introduction 
Levels of 1.5-keto-13,14-dihydro metabolites of 
prostaglandins (PCs) Ez and FZol in plasma reflect 
more accurately PG biosynthesis than levels of the 
primary PGs [l]. However, so far there are only few 
reports on the development of radioimmunoassays 
for the PGE, metabolite 15-keto-13,14-dihydro- 
PGEz (KH2PGE2) [2-51. Furthermore, the reliability 
of these assays eems to be lower than the reliability 
of radioimmunoassays for the corresponding PGF,, 
metabolite [5,6]. This is probably a consequence of
the chemical instability of KH2PGE2, which is easily 
dehydrated to KHzPGAz [6,7]. KHZPGA2 can bind 
to proteins and, under certain conditions like alkaline 
pH or in the presence of albumin, rearrange to the 
stable bicyclic degradation end product 11 -deoxy- 
15-keto-13 ,14-dihydro-l l ,16-cycle-PGE? (DKH*- 
cycle-PGE,) [6-81. We have described the first radio- 
immunoassay for KH2PGE2 [2]. Now we show that 
antisera obtained from rabbits immunized with a 
KHzPGEz-conjugate contain not only antibodies 
against KH,PGE,, but also against the KHzPGEz 
dehydration products KHIPGAz and DKH,-cyclo- 
PGE2. The three antibody populations differ in their 
specificities as well as in their association constants. 
With [3H]KHzPGEz or the tritiated dehydration 
products as tracers the same antisera can be used for 
radioimmunoassays of KH,PGE*, KH2PGAZ and 
DKH+yclo-PGE,, the specificity and sensitivity of 
the assays being dependent on the labelled ligand 
used. The radioimmunoassays for KH2PGE, and 
KH,PGA* may be used for the direct determination 
of these compounds under defined conditions. Thus, 
the radioimmunoassay for KH,PGA2 may be espe- 
cially useful for the determination of the PGE2 
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metabolite, when rapid decomposition of KH,PGEz 
occurs, but is suspended with the formation of 
KH*PGA* as, e.g., during incubation of KHzPGEz in 
the absence of albumin at neutral pH and elevated 
temperatures [7]. Since in the presence of albumin 
both KH*PGE, and KHzPGAz are not stable and are 
further transformed to DKH+yclo-PGE, [6,7], the 
radioimmunoassay for DKH,-cycle-PGE, might be 
used for the determination of the PGEz metabolite 
in plasma fter conversion to the stable dehydration 
end product as proposed [B]. However, as DHK2- 
cycle-PGE, exists in at least hree epimerically dis- 
tinct forms [7], a specificity problem of the radio- 
immunoassay could emerge at the epimeric level. So 
far the epimeric ratio formed under various condi- 
tions cannot be controlled [7]. Nevertheless, the 
anti-DKH,-cyclo-PGE, antibodies described here 
may be especially useful for the radioimmunological 
determination of KHzPGEz after dehydration in 
biological material, since these antibodies were pro- 
duced after immunization with a conjugate synthe- 
sized originally with KH2PGE2 as hapten and may, 
therefore, specifically recognize the epimer(s) formed 
from KH,PGE, under quasi-physiological onditions. 
2. Materials and methods 
KH2PGE2, KHZPGA2 and DKHz-cycle-PGE* as 
well as other PCs and thromboxane Bz (TXB2) were 
a generous gift of Dr J. Pike, Upjohn Co., Kalamazoo, 
MI. Their purity was checked by thin layer chroma- 
tography in the following solvent systems: chloro- 
form/tetrahydrofuran/acetic acid (100: 10:5); ethyl 
acetate/H,O/isooctane/acetic acid (110: 100:50:20, 
upper phase); and water-saturated diethyl ether. Only 
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the latter solvent system separated KH$GA? from 
DKH,-cycle-PGEs sufficiently (RF values 0.61 and 
0.67, respectively). DKH,-cycle-PGE, was a mixture 
of at least hree epimers (F. A. Fitzpatrick, Upjohn 
Co., Kalamazoo, personal communication), which 
could not be separated. [5,6&l 1 ,14-3H]KHzPGEz 
(spec. act. 70 Ci/mmol) was obtained from New 
England Nuclear Co., Dreieichenhain. The labelled 
ligand for the radioimmunoassay of KH,PGA2 was 
prepared by incubation of 5 MCi [3H]KH2PGE2 in 
0.5 ml 0.1 M Tris-HCl buffer (pH 8.0) at 37’C for 
18 h. After acidi~cation to pH 3.5 the material was 
extracted into 2 X 4 vol. ethyl acetate and purified 
by thin-layer chromatography. Similarly, the labelled 
ligand for the radioimmunoassay of DKH,-cyclo- 
PGE, was prepared by incubation of 25 @i 
[‘H]KH2PGE2 at 37°C for 18 h in 1 ml human 
plasma depleted of endogenous PG by charcoal 
adsorption [9]. The labelled material was extracted 
and purified as above. The radioactivity co-chroma- 
tographing with authentic KHsPGA2 or DKHs-cyclo- 
PGE2, respectively, was scraped off and eluted with 
5 ml methanol. Possible pimers of the tritiated prod- 
uct co~hromatograph~g with DKH*-cycle-PGE* 
were not separated. The synthesis of an immunogenic 
KH,PGE,-bovine serum albumin conjugate as well as 
the production and specificity of antisera gainst 
KHsPGE2 have been described [2]. Binding parame- 
ters for antibody popu~tions used under radio- 
~munoassay conditions were determined according 
to [lo] using the central linear part of Scatchard 
plots [ 111. The plots were corrected for non-specific 
binding to normal rabbit serum, which was used in 
the same dilutions as the antisera. Radioimmuno- 
assays were perfo~ed as in [9]. Samples were 
incubated at 4’C overnight and 0.5 ml charcoal sus- 
pension (20 mg/ml) was used to separate free and 
antibody-bound fractions of antigen. 
3. Results and discussion 
Rabbits immunized with KH,PGE,-bovine serum 
albumin conjugates produced antisera, which not 
only bound the homologous hapten KH2PGE2, but 
also its degradation products KH,PGA, and DKH,- 
cycle-PGEs. As albumin promotes the formation of 
DKH+yclo-PGE, from KHzPGEz [6,7], part of the 
hapten might have already been transformed uring 
preparation of the immunogen. Further dehydration 
could have occurred after injection of the immu- 
nogen. The b~d~g parameters of such an ~tiserum 
according to [lo] for the three haptens are shown in 
table 1, The binding constants for KH2PGE2 and 
KHzPGAz are clearly lower than the binding constant 
for the stable degradation end product DKHrcyclo- 
PGE,. Binding of KHsPGE, and KH2PGA2 to the 
antiserum isnot due to partial conversion of these 
compounds to DKHs-cycle-PGE, during the radio- 
immunoassay incubation, Using thin layer chroma- 
tography of labelled compounds after the incu- 
bation, formation of DKHTcyclo-PGE, from either 
KHzPG& or KHzPGAz was not detected. However, 
there was some formation of KH2PGA2 from KHZ PGEz 
(~5-10%) during the incubation under the condi- 
tions used (4’C, 18 h). The binding parameters given 
for KHsPGE? may, therefore, be slightly influenced 
by the instability of this compound uring the incu- 
bation. 
The specificity of the radio~unoas~ys for 
KH2PGE,, KH,PGA2 and DKH+yclo-PGE, using 
the same antiserum but different racers is illustrated 
in table 2. The antibody population used in the 
radio~munoas~y for KHzPGEz recognizes the 
homologous hapten and KHzPGAz equally well, 
while the relative crossreaction of DKH,-cycle-PGEs 
is (0.06%. The crossreaction of the anti-KHIPGEz 
antisera with other PGs and PG metabolites has been 
June 1980 
Table 1 
Binding parameters according to fl l] of antibody populations against KH,PGE,, KH,PGA, 
and 1 ldeoxy-15keto-13,14dihydro-I 1,16-cycle-PGE, 
Final antiserum dilution 
used in radioimmunoassay 
K, Wmol) A, (moJ/l) 
15-keto-13,14d~ydro-PGE~ 1:3000 6.8 x 108 
15~eto-l3,14d~ydro-PGA~ 1:3000 9.7 x 10s 
1 ldeoxy-15keto-I 3,14- 
dihydro-1 1 ,I(i-cyclo-PGE, 1:160 000 2.3 x IO’O 
A,, concentration of antibody sites; Ka, intrinsic association constant 
6.0 X lo-“’ 
4.8 X lo-*(’ 
0.4 x lo-‘@ 
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Table 2 
Speeiftcities ofanti-PGE, metabolite antiserum depending on Welled antigen used 
Inhibitor (ng) 50% displacement of labelled ligand in radioimmunoassay for
June 1980 
KH,PGE, KH,PGA, lldeoxy-15-k&o-13,14- 
dihydro-1 1 ,I 6_cycdoBGE, 
KH,PGE, 0.6 5.2 65.0 
RH, PGA, 0.6 0.6 55.0 
lldeoxy-15keto-l3,54- 
dihydro-1 1,16_cyclo-PGE, >I000 >lOOO 0.04 
For fmal ;urtiserum dilutions used with tie tracers ee table I 
described f2). In the KHzPGAz radioimmunoassay 
KH,PGA* is the most potent inhibitor of binding of 
label to antisesum (table 2). The relative crossreaction 
of KH,PGE, is considerable (1 1 .5%), while that of 
DKH,-c~cIo-PG& is <OXI&& (table 2). The cross- 
reaction of PGAz is I .4% and that of all other corn- 
pounds tested (PGE2, PGE,, PGF,,, PGF,,, PGDz, 
PGD,, 6-keta-PGF1,, 1 Sketo-PCE,, 1 5-keto-PGFZ,, 
13,lQdihydro-15”keto-PGF2,, TXB? and 13,14- 
dihydro-1 5-keto-TXB2) is -C&06%. The radioimrnu- 
noassay for DK&cyclo-PGEz is highIy specific, the 
relative crossreaction of KHzPCEz and KH2PGA2 
being only 0.06% and 0.07%, respectively (table 2). 
The interference of all other PCs and PG metabolites 
as well as of TX& in this radi~~uno~~y is 
negligible (relative crossreaction <O.itl%). Obviously 
the b&cyclic structure of the KHzPGEz degradation 
product as compared to the typical structure of 
primary PGs and PG metabolites results in different 
immunodominant parts of the hapten molecule, In 
accordance with the higher avidity of the antibodies 
(table I) the sensimty of the ra~o~unoas~y 
for DKH+zyclo-PGE, is considerably higher than 
that for KHtPGJ& and KH2PGA2, 40 pg causing 
50% inhibition of binding of label to the antiserum 
(table 2) and the detection limit (10% inhibition of 
binding of label) being 4 pg. 
Our results how, that antibodies can be produced 
against compounds like KHzPGEz and KHzPGA2, 
which are not completely stable under physiological 
conditions. However, as expected, the avidity of these 
antibodies is lower than the avidity of antibodies 
against the stable degradation product DKHrcqrclo- 
PGE1. The use of stable hapten mimics instead of 
labile natural compounds for immunization has been 
suggested to produce antisera of high avidity and 
specificity [ 121 and this method might also be suit- 
able for the production of anti-KH,PGE& antisera, 
which could be used for sensitive radioimmunoassays, 
The relatively low avidity of the antibodies against 
KHzPGEz and KH,PGA, may prevent heir use for 
ra~o~unolo~~ dete~ation of low amounts 
of the haptens in biological material. Thus, while the 
sensitivity of our radioimmunoassay for KH2PGE2 
was sufficient o determine the considerable concen- 
trations of the PGEz metabolite found in freshly 
prepared extracts of human gastric. juice f13], it was 
not possible to detect plasma levels of KH$GE,, 
which are in the low pglml range [ 141. 
A radioimmunoassay for KH,PGA2 has so far not 
been described. This assay may be especially useful 
for the determination of the PGE, metabolite under 
conditions, where rapid dehydra~on of KH$G& to 
KHzPGAz takes place, but binding to albumin and/or 
cyclization to DKH+yclo-PGE, does not occur as, 
e.g., during incubation of KH2PGE2 in protein-free 
solutions at neutral pH and elevated temperatures 
f7]. Similarly, large amounts of KH,PGA2 are formed 
from KHzPGE2 during extraction from aqueous olu- 
tions in’to organic solvents at acid pH fl3]. 
A radioimmunoassay for DKH,-cycle-PGE, was 
described [8]. It was suggested that PGEz metabolite 
be measured as DKH?-cycle-PGEz after complete 
chemical conversion. Certainly, one can expect a 
greater eliability of assay results from this method, 
as, contrary to KH2PGE2, DKH,-cycle-PGE, is stable 
under various experimental conditions. However, 
DKHz-cyclo-PGE, exists in at least three epimerically 
distinct forms 171, the ratio of which formed during 
various conversion procedures cannot yet be con- 
trolled 171. Valid dete~ation of KH$GE, as 
DKHz-cycle-PGE, requires that the anti-DKH,-cyclo- 
PGE1! antibodies used recognize specifically the 
epimer(s) of the degradation product formed by the 
Volume 115, number 1 FEBS LETTERS June 1980 
conversion procedure. The anti-DKH,-cycle-PGE, 
antibodies described here were raised by immuniza- 
tion with an immunogen synthesized originally with 
KHzPGEz as hapten [2]. These antibodies are, there- 
fore, most probably directed against the epimer or 
mixture of epimers of DKH,-cycle-PGE, formed 
from KH*PGE, under quasi-physiological onditions. 
Consequently, the anti-DKH+yclo-PGE, antibodies 
described here are possibly more suitable for use in 
radioimmunoassay than antibodies raised by immu- 
nization with conjugates of epimeric mixtures of 
DKH,-cycle-PGE,. Furthermore, the labelled ligand 
for our radioimmunoassay was also synthesized from 
[3H]KHzPGEz under quasi-physiological onditions. 
The possible use of this radioimmunoassay for DKH2- 
cycle-PGE, for specific determination of KH,PGEa 
in biological material after conversion to the stable 
dehydration product is under investigation. 
Acknowledgement 
This work was supported by the Deutsche For- 
schungsgemeinschaft . 
References 
[ 1 ] Samuelsson, B., Granstriim, E., Green, K., Hamberg, M. 
and Hammarstrom, S. (1975) Ann. Rev. Biochem. 44, 
669-695. 
[ 21 Peskar, B. A., Holland, A. and Peskar, B. M. (1974) 
FEBS Lett. 43,45-48. 
[3] Gordon, D., Myatt, L., Gordon-Wright, A., Hanson, J. 
and Elder, M. G. (1977) Prostaglandins 13, 399-408. 
[4] Levine, L. (1977) Prostaglandins 14,1125-1139. 
[5] Mitchell, M. D., Sors, H. and Flint, A. P. F. (1977) 
Lancet ii, 558. 
[6] Granstrom, E. (1979) in: Radioimmunoassay of drugs 
and hormones in cardiovascular medicine (Albertini, A. 
et al. eds) pp. 229-238, Elsevier/North-Holland, 
Amsterdam, New York. 
[ 71 Fitzpatrick, F. A., Aguirre, R., Pike, J. E. and Lincoln, 
F. H. (1980) Prostaglandins in press. 
[8] Granstrom, E. and Kindahl, H. (1979) in: 4th Int. 
Prostaglandin Conf., Washington, abstr. p. 42. 
[9] Peskar, B. M., Holland, A. and Peskar, B. A. (1974) 
Clin. Chim. Acta 55,21-27. 
[lo] Kahn, D., Andrieu, J. M. and Dray, F. (1974) Immuno- 
chemistry 11,327-332. 
[ 111 Scatchard, G. (1949) Ann. NY Acad. Sci. 51,660-672. 
[12] Fitzpatrick, F. A. and Bundy, G. L. (1978) Proc. Natl. 
Acad. Sci. USA 75,2689-2693. 
[ 131 Peskar, B. M., Seyberth, H. W. and Peskar, B. A. (1980) 
in: Advances in prostaglandin and thromboxane 
Research (Samuelsson, B. et al. eds) vol. 8, Raven, 
New York, in press. 
[14] Samuelsson, B. and Green, K. (1974) Biochem. Med. 
11,289-303. 
126 
